EUDA Health (NASDAQ:EUDA – Get Free Report) was upgraded by equities researchers at Greenridge Global to a “strong-buy” rating in a research report issued to clients and investors on Monday,Zacks.com reports.
EUDA Health Trading Down 1.2 %
Shares of EUDA Health stock opened at $4.06 on Monday. EUDA Health has a 12-month low of $1.20 and a 12-month high of $6.30. The company has a 50-day simple moving average of $4.52 and a 200 day simple moving average of $4.04.
About EUDA Health
Featured Stories
- Five stocks we like better than EUDA Health
- 3 Fintech Stocks With Good 2021 Prospects
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- 5 Top Rated Dividend Stocks to Consider
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- The Role Economic Reports Play in a Successful Investment Strategy
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.